Angiotensin-converting enzyme gene and endothelial nitric oxide synthase gene polymorphisms in Behçet's disease with or without ocular involvement

Inflamm Res. 2009 Jul;58(7):401-5. doi: 10.1007/s00011-009-0005-y. Epub 2009 Mar 3.

Abstract

Purpose: The association of known ACE gene and eNOS gene polymorphisms with BD in a group of Turkish patients with or without ocular involvement has been investigated.

Methods: The ACE and eNOS gene polymorphisms were investigated in 73 BD patients and 90 controls.

Results: The distrubition of "DD", "ID" and "II" genotypes of the ACE gene were 32 (43.8%), 29 (39.8%) and 12 (16.4%) for BD patients and 32 (35.5%), 35 (38.9%) and 23 (25.6%) for healthy controls. There was no significant difference between the groups (p = 0.140, OR 1.44, CI 0.90-2.30). When Behçet patients with ocular involvement were compared to the control group, statistical significance was found (p = 0.049, OR 2.18, CI 1.00-4.81). The "bb", "ba", and "aa" genotype frequencies of the eNOS gene were 48 (65.8%), 23 (31.5%), and 2 (2.7%) for patients with BD and 75 (83.3%), 15 (16.7%), and 0 (0%) for healthy controls, respectively. The significant difference found in allelic frequencies between the two groups (p = 0.011, OR 2.32, CI 1.11-4.87). When Behçet patients with ocular involvement were compared, sharper statistical significance was found (p = 0.001,OR 4.61,CI 1.85-11.52).

Discussion: The ACE gene polymorphism does not play a role in the pathogenesis of BD. The findings of the eNOS gene polymorphisms confirmed the significant association with BD and even more in patients with ocular involvement.

MeSH terms

  • Behcet Syndrome / complications
  • Behcet Syndrome / genetics*
  • Case-Control Studies
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Male
  • Nitric Oxide Synthase Type III / genetics*
  • Panuveitis / genetics*
  • Peptidyl-Dipeptidase A / genetics*
  • Polymorphism, Genetic
  • Retinal Vasculitis / genetics*
  • Turkey / epidemiology

Substances

  • NOS3 protein, human
  • Nitric Oxide Synthase Type III
  • Peptidyl-Dipeptidase A